Insulin resistance may cause a metabolic syndrome but whether insulin resistance causes hypertension is very controversial. Furthermore, it remains unclear whether the link between the insulin-resistance-related metabolic syndrome and hypertension is different between men and women. We examined fasting insulin, glucose, triglyceride and high-density lipoprotein (HDL)-cholesterol levels, systolic blood pressure, body mass index, and waist-to-hip ratio in a dataset from 8437 nondiabetic residents (age range, 30 to 89 years) in Kinmen. Factor analysis, a multivariate correlation statistical technique, was used to investigate the clustering and interdependence of these risk variables. Factor analysis identified two factors for men (n ‫؍‬ ‫؍‬ 3659) and three factors for women (n ‫؍‬ ‫؍‬ 4778, respectively. In men, a cluster of insulin, triglyceride, HDL-cholesterol, body mass index, and waist-to-hip ratio (metabolic syndrome) accounted for 29.7%, and a cluster of systolic blood pressure and glucose (hyperglycemia plus hypertension) accounted for 18.1% of the total variance in all variables considered. In women, a cluster of insulin, triglyceride, body mass index, waist-to-hip ratio, and systolic blood pressure (metabolic syndrome plus hypertension) accounted for 29.4%, a cluster of systolic blood pressure, glucose, and triglyceride (hyperglycemia plus hypertension plus dyslipidemia) accounted for 14.0%, and a cluster of triglyceride and HDLcholesterol (dyslipidemia) accounted for 16.2% of the total variance.
G lucose intolerance, hyperinsulinemia, increased very-low-density lipoprotein triglyceride, decreased high-density lipoprotein (HDL)-cholesterol, and hypertension are all established risk factors for cardiovascular disease. Insulin-mediated resistance to glucose uptake may be responsible for the clustering of these risk variables and the term "syndrome X" was first proposed by Reaven 1 and has expanded and evolved to various terminology, such as "insulin resistance syn-drome" or "insulin resistance metabolic syndrome." 2, 3 New additions to the syndrome mainly include obesity, 4 visceral adiposity, 3 and other risk variables, such as microvascular angina, hyperuricemia, and plasminogen activator inhibitor-1. 5 However, in clinical settings or epidemiologic studies, the existence of the insulin resistance syndrome is hard to define, as not all features of the syndrome are present in the same individual. 3, 6 Insulin resistance and the compensatory hyperinsulinemia are the characteristic features of glucose intolerance 3, 7, 8 and obesity, 1, 4 and are also directly responsible for the dyslipidemia. 4, 9 However, the relationship between hypertension and insulin resistance is more controversial. About half of patients with hypertension can be considered to have insulin resistance and hyperinsulinemia. 10 Direct association of blood pressure and fasting serum insulin level independent of obesity, glucose intolerance, and other common confounders, such as age, gender, and treatment, has been shown in some [11] [12] [13] [14] [15] but not other population-based studies. 16 -21 In addition, there is evidence of gender difference in the insulin sensitivity [22] [23] [24] and the relationship between blood pressure and insulin levels. 3, 6 Even in populations where insulin and blood pressure are directly associated, it remains uncertain whether the metabolic abnormalities play a part in the blood pressure regulation. 10 The clustering of risk variables in a population may simply reflect correlations among these variables, such that they tend to occur together, or they may reflect the existence of a common underlying mechanism. One statistical method of interpreting the interdependence of risk variables is factor analysis. [25] [26] [27] [28] [29] It is a multivariate correlation technique that allows extraction of common components among multiple associated variables. Factor analysis accounts for the overlapping variability of interrelated variables by defining a set of new composite independent hypothetical variables (factors). 28 Risk variables sharing a common pathophysiologic mechanism may have greater degrees of overlapping variability than other variables involving different mechanisms, and may cluster to define a composite variable (factor) during factor analysis. On the other hand, component risk variables of different factors generated during factor analysis may be considered pathophysiologically independent. By factor analysis a distinct metabolic syndrome characterized by hyperinsulinemia, dyslipidemia, and obesity was identified in the Framingham Offspring Study, in which hypertension was linked to the metabolic syndrome through obesity. 29 Interestingly, in other studies weight/waist, blood pressure, lipids, and insulin/glucose were identified as independent composite factors that may reflect separate underlying mechanisms of the insulin resistance syndrome. 25, 27 Thus, the purposes of the present study were to examine, using factor analysis, whether a discrete insulin-related metabolic syndrome exists in a homogeneous Chinese population; whether the metabolic syndrome links to hypertension; and whether there is a gender difference in the link between the metabolic syndrome and hypertension.
MATERIALS AND METHODS
Study Population Kinmen county of Taiwan has a population of around 45,000 residing on one principal island (Quemoy) and several nearby islets; all are very close to the southern mainland of China. 30 During the period 1991 to 1995, all residents older than 30 years of age in five major townships (Kin-Hu, 30 Kin-Chen, 31 Kin-Sa, Kin-Nin, and Lieh-Yu) in Kinmen were surveyed by the Yang-Ming Crusade, a volunteer organization of the medical students from the National Yang-Ming University. 31 The overall response rate was 62.5%, based on a target population of 20,185 by household registration. Because fasting serum insulin levels were not available during the pilot survey for Kin-Hu, 30 the data from the remaining four townships were used for current investigation.
Demographic and clinical parameters including body height, body weight, body mass index (weight/ height 2 ), waist-to-hip ratio, 32 systolic and diastolic blood pressure (averages from three readings separated by at least 5 min) were documented from doorto-door interviews with structured questionnaire.
Overnight fasting serum and plasma samples were drawn for glucose, insulin, lipid, and other biochemical measurements. Fasting plasma glucose was determined by the hexokinase-glucose-6-phosphate dehydrogenase method with glucose (HK) reagent kit (Gilford, Oberlin, OH). Fasting serum insulin was measured by radioimmunoassay (Incstar Co., Stillwater, MN). The detection limit was 2.05 U/mL. The intra-and interassay coefficients of variation were 7.4% and 9.1%, respectively.
Overweight was defined as body mass index Ͼ 25 kg/m 2 and obesity as body mass index Ͼ 30 kg/m 2 for both men and women. 33 Hypertension was defined as systolic blood pressure of Ն 140 mm Hg, diastolic blood pressure of Ն 90 mm Hg, or taking antihypertensive medication. 34 The criteria for the diagnosis and classification of diabetes mellitus proposed by the American Diabetes Association were adopted in this study. 35 Subjects with a medical history of diabetes were considered diabetic. For subjects without a history of diabetes, one fasting plasma glucose level Ն 126 mg/dL was considered diabetic. Subjects with fasting plasma glucose levels Ͻ 110 mg/dL were categorized as having normal fasting glucose. 35 For the purpose of the present analysis, subjects with diabetes and those with missing laboratory data were excluded. Thus, the nondiabetic group included those with normal fasting glucose and with impaired fasting glucose (fasting plasma glucose levels Ն 110 mg/dL and Ͻ 126 mg/dL). 35 The final population for this analysis included 3659 men and 4778 women with a mean age of 49.2 Ϯ 12.6 years (range, 30 to 89 years). This represented 67% of all respondents from the surveys.
Statistical Analysis All statistical analyses were carried out using the SAS statistical package (SAS Inc., Cary, NC). Characteristics of the population sample were summarized with means and standard deviations.
Student's t test was used to compare the gender difference in each characteristic. Univariate Pearson's correlation coefficients between variables were calculated.
Factor analysis was performed in steps of principal component analysis, rotation of principal components, and interpretation of factors. Principal component analysis based on the criteria of eigenvalues Ͼ 1.0 was used to extract the initial set of uncorrelated components that were linear combinations of the original variables. The components were orthogonally rotated through processes of maximizing and minimizing factor loadings to obtain the more clearly defined factors. Factor loadings are equivalent to a Pearson's correlation coefficient between each variable and each factor. Absolute values of factor loadings Ն 0.25 were considered for factor pattern interpretation.
Because systolic and diastolic blood pressures are highly correlated and they often appear as one factor during factor analysis, [27] [28] [29] the potential association of blood pressure with other risk variables may have been obscured. Thus, factor analysis was repeated with removal of the diastolic blood pressure. Further, factor analysis was performed in women stratified by menopausal status to reveal its impact on the metabolic risk factor profiling. Lastly, factor analysis was performed for a subpopulation with normal fasting glucose and never receiving any antihypertensive agents. Values for insulin and triglyceride levels were log-transformed to improve normality. Table 1 displays the gender-stratified descriptive summary for the entire population. The gender difference of the risk variables in this population was similar to those described in Kin-Chen previously. 31 Table 2 displays the correlation matrix of risk variables for men and women. Each variable was significantly correlated with every other risk variable between both genders. The strongest correlation was between systolic and diastolic blood pressure (0.66 for men and 0.70 for women, respectively). All other correlation coefficients were Ͻ 0.35.
RESULTS

Characteristics of the Study Population
Intercorrelations of Risk Variables
Factor Analyses for Risk Variables
For the entire population, factor-loading patterns after principal component analysis and orthogonal rotation of the correlation matrix are displayed in Table 3 . Three dominant factors were identified underlying the clustering of risk variables for both men and women. In men, systolic and diastolic blood pressures were associated with one factor (hypertension), which explained 28.6% of the total variance in all variables considered. Fasting insulin, triglyceride, and HDL-cholesterol levels, body mass index, and waist-to-hip ratio were associated with a second factor (metabolic syndrome), which explained an additional 17.6% of the total variance. Fasting plasma glucose alone represented the third factor (hyperglycemia), which accounted for 15.5% of the total variance. In women, systolic and diastolic blood pressures were associated with one factor (hypertension), which explained 29.5% of the total variance. Insulin, triglyceride, HDL-cholesterol, body mass index, and waist-to-hip ratio were associated with a second factor (metabolic syndrome), which explained an additional 16.0% of the total variance. Glucose and triglyceride were associated with a third factor (hyperglycemia plus dyslipidemia), which accounted for 16.6% of the total variance. Factor analysis was repeated with removal of diastolic blood pressure and the results are shown in Table 4 . Factor analysis identified two factors for men and three factors for women, respectively. In men, a cluster of insulin, triglyceride, HDL-cholesterol, body mass index, and waist-to-hip ratio (metabolic syndrome) accounted for 29.7%, and a cluster of systolic blood pressure and glucose (hyperglycemia plus hypertension) accounted for 18.1% of the total variance in all variables considered. In women, a cluster of insulin, triglyceride, body mass index, waist-to-hip ratio, and systolic blood pressure (metabolic syndrome plus hypertension) accounted for 29.4%, a clus- ter of systolic blood pressure, glucose, and triglyceride (hyperglycemia plus hypertension plus dyslipidemia) accounted for 14.0%, and a cluster of triglyceride and HDL-cholesterol (dyslipidemia) accounted for 16.2% of the total variance.
In the study population, 46.2% of women were menopausal. The linking of metabolic syndrome with hypertension in women was present regardless of menopausal status (Table 5 ). However, premenopausal women differed from their postmenopausal counterparts in that triglyceride was not a component of the "metabolic syndrome plus hypertension" factor. In addition, the linking of hypertension with hyperglycemia and dyslipidemia appeared to be present only in the premenopausal women.
For the subgroup of normal fasting glucose without taking antihypertensive medication, the factor loading patterns were similar to those for the entire population except that systolic blood pressure barely reached the criteria of 0.25 for interpretation of the third factor in women (Table 6) .
DISCUSSION
In this large homogeneous nondiabetic Chinese population, we confirmed the existence of an insulinresistance-related metabolic syndrome characterized by hyperinsulinemia, dyslipidemia, and obesity in both men and women. 29 The metabolic syndrome was linked to hypertension in women but not in men. In men, the factor-loading pattern revealed two factors (first factor, metabolic syndrome; second factor, hyperglycemia plus hypertension) that did not share common risk variables. This may imply that in men, blood pressure regulation shares a common underlying physiologic mechanism with glucose regulation independent of the mechanism responsible for the metabolic syndrome. On the other hand, three factors (first factor, metabolic syndrome plus hypertension; second factor, hyperglycemia plus hypertension plus dyslipidemia; third factor, dyslipidemia) were identified with overlapping risk variables in women. This may imply that in women, blood pressure regulation shares a common underlying physiologic mechanism with the metabolic syndrome (ie, insulin resistance), in addition to the association with glucose regulation similar to that in men. These results demonstrate a gender difference in the relationship between insulin resistance and hypertension. Specifically, insulin resistance and hypertension may be mechanistically associated in women. 10 The direct linking between insulin resistance and hypertension in women is present regardless of menopausal status.
Factor analysis has been used to elucidate the risk factor clustering in the insulin resistance syndrome in various ethnic groups, including diabetic and nondiabetic American Indians, 28 nondiabetic white American women, 25 diabetic and nondiabetic Japanese-American men, 27 and nondiabetic white Americans. 29 In studies where both systolic and diastolic blood pressures were included in the factor analysis, a separate factor characterized by large factor loadings for systolic and diastolic blood pressure variables usually emerged, 25, [27] [28] [29] as in our study. The emergence of a separate factor for blood pressure variables may lead to the conclusion that hypertension is not a characteristic of the insulin resistance syndrome and may imply that hypertension and insulin resistance are not causally related. [27] [28] [29] However, in one study where diastolic blood pressure was not included in the factor analysis, systolic blood pressure did cluster with fasting and postload insulin and glucose in women. 25 Although systolic and diastolic hypertension may have different pathophysiologic significance, 36 they are usually highly correlated and should share a lot of common hemodynamic information. The inclusion of the two highly correlated variables may amplify the representative percentage of the total variance of all variables and may inevitably force the emergence of a separate blood pressure factor in the factor analysis and obscure the potential linking of blood pressure with other risk variables.
It has been hypothesized that the insulin-resistancerelated metabolic abnormalities are linked to hypertension by a pathophysiologic process that involves the sympathoadrenal system and exerts both prohypertensive and atherogenic effects. 10 Two possible pathways have been proposed: insulin resistance with resultant compensatory hyperinsulinemia activates sympathetic activity that subsequently causes hypertension, 10 or, the other way around, an increased sympathetic activity is the basic pathophysiologic underpinning of the frequent association of insulin resistance and hypertension. 37 In this study, a factor with components of fasting blood glucose and systolic blood pressure emerged in both men and women. This supports the notion that the sympathetic activity is related to blood pressure regulation, because both higher blood pressure and hyperglycemia are part of the defense response (fight or flight) mediated mainly through sympathoadrenal activation. 37 Furthermore, our results appear to suggest that the role of sympathetic activity in the pathogenesis of hypertension may be different between men and women. Specifically, in men, the sympathetic overactivity may be the culprit for hypertension because the insulin-resistance-related metabolic syndrome was not linked to hypertension. On the other hand, insulin resistance may be the initiator for hypertension in women because the insulin-resistance-related metabolic syndrome and hypertension were components of the same factor. Alternatively, blood pressure in men appears to be more dependent upon the sympathetic activity and in women, it appears to be more dependent upon the insulin resistance.
Women appear to be less insulin resistant than men, and the higher insulin sensitivity in women may be responsible for the lower cardiovascular risk observed in epidemiologic studies. 22, 23 Our results suggest that hypertension in women may be more dependent upon insulin resistance than in men and this dependency is not affected by menopausal status (Table 5 ). However, menopausal status appears to impact the metabolic risk factor profiling in women. The linking between hypertension and hyperglycemia appeared in premenopausal women (Table 5) . After menopausal, hypertension was linked to the metabolic syndrome only and dyslipidemia was manifested as a component of the metabolic syndrome. This may support the observation that postmenopausal women are more insulin resistant than their premenopausal counterparts. 38 -40 This may partly explain the much lower prevalence of hypertension in women than in men before age 60 in this population. 30, 31 There is an obvious ethnic difference in the relationship between hypertension and insulin resistance syndrome. 41 Hypertension may not be associated with insulin resistance in American Indians, 41, 42 African Americans, 41 or Pacific Islanders, 19 as it is in white populations. 43, 44 In Chinese populations mixed results were observed. It has been demonstrated in Taiwan Chinese that patients with hypertension are glucose intolerant and hyperinsulinemic when compared with a matched group of individuals with normal blood pressure. 45 In Chinese residents living in Kin-Chen we have demonstrated that both insulin and C-peptide are significantly associated with systolic and diastolic blood pressure. 15 However, no association between blood pressure and insulin was shown in a Chinese population in Mauritius. 21, 46 This may suggest that environmental factors, especially dietary factors, are involved in the pathogenesis of insulin resistance and the relationship between hypertension and insulin resistance. 10 In conclusion, a distinct insulin-resistance-related metabolic syndrome characterized by hyperinsulinemia, dyslipidemia, and obesity was observed for both men and women in this large homogeneous nondiabetic Chinese population. However, hypertension was linked to the metabolic syndrome in women only. This may imply different pathophysiologic links between insulin resistance and hypertension in men and women.
